booster
Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021
Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 bi
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
3
举报
登录后可参与评论
暂无评论